Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2025)
Collegium Pharmaceutical (COLL) posted quarterly Other Operating Expenses of -$19000.0 for Q4 2025, up 99.85% year-over-year from -$9507.3 in Q4 2024, and up 99.83% quarter-over-quarter from -$10.9 million in Q3 2025.
Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2025) Analysis & Trends
Collegium Pharmaceutical's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$19000.0 for Q4 2025.
- In Q4 2025, Other Operating Expenses rose 99.85% year-over-year to -$19000.0; the TTM figure through Mar 2026 stood at -$21.1 million (up 49.84% YoY), while the FY2025 annual figure was -$1.2 million, up 96.77% from the prior year.
- Other Operating Expenses for Q4 2025 stood at -$19000.0, up from -$10.9 million in the prior quarter.
- The five-year high for Other Operating Expenses was -$19000.0 in Q4 2025, with the low at -$14.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Collegium Pharmaceutical | 892.02 Mn | 742.71 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | -10.92 Mn |
| Jun 30, 2025 | -10.16 Mn |
| Mar 31, 2025 | -14.08 Mn |
| Dec 31, 2024 | -12.39 Mn |
| Sep 30, 2024 | -7.80 Mn |
| Jun 30, 2024 | -7.81 Mn |
| Mar 31, 2024 | -8.62 Mn |
| Dec 31, 2018 | 29.73 Mn |
| Sep 30, 2018 | 46.01 Mn |
| Jun 30, 2018 | 46.84 Mn |
| Mar 31, 2018 | 43.11 Mn |
| Dec 31, 2017 | 1.09 Mn |
| Sep 30, 2017 | 553,000.00 |
| Jun 30, 2017 | 577,000.00 |
| Mar 31, 2017 | 371,000.00 |
| Dec 31, 2016 | 184,000.00 |
| Sep 30, 2016 | 29,000.00 |